Publications:
A selected list of publications:
Petersenn Stephan, Farrall Andrew J, Block Christophe, Melmed Shlomo, Schopohl Jochen, Caron Philippe, Cuneo Ross, Kleinberg David, Colao Annamaria, Ruffin Matthieu, Hermosillo Reséndiz Karina, Hughes Gareth, Hu Ke, Barkan Ariel
Long-term efficacy and safety of subcutaneous pasireotide in
acromegaly: results from an open-ended, multicenter, Phase II
extension study
Pituitary,
2013; 43(2):
.
Hartman Mark L, Xu Rong, Crowe Brenda J, Robison Leslie L, Erfurth Eva Marie, Kleinberg David L, Zimmermann Alan G, Woodmansee Whitney W, Cutler Gordon B, Chipman John J, Melmed Shlomo, Melmed Shlomo
Prospective safety surveillance of GH-deficient adults: comparison of
GH-treated vs untreated patients
The Journal of clinical endocrinology and metabolism,
2013; 98(3):
980-8.
Thakker Rajesh V, Newey Paul J, Walls Gerard V, Bilezikian John, Dralle Henning, Ebeling Peter R, Melmed Shlomo, Sakurai Akihiro, Tonelli Francesco, Brandi Maria Luisa, Brandi Maria Luisa
Clinical practice guidelines for multiple endocrine neoplasia type 1
(MEN1)
The Journal of clinical endocrinology and metabolism,
2012; 97(9):
2990-3011.
Chesnokova Vera, Zonis Svetlana, Wawrowsky Kolja, Tani Yuji, Ben-Shlomo Anat, Ljubimov Vladimir, Mamelak Adam, Bannykh Serguei, Melmed Shlomo
Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph
adenoma growth
Molecular endocrinology (Baltimore, Md.),
2012; 26(12):
2092-103.
Chesnokova Vera, Zonis Svetlana, Zhou Cuiqi, Ben-Shlomo Anat, Wawrowsky Kolja, Toledano Yoel, Tong Yunguang, Kovacs Kalman, Scheithauer Bernd, Melmed Shlomo
Lineage-specific restraint of pituitary gonadotroph cell adenoma
growth
PloS one,
2011; 6(3):
e17924.
Webb Susan M, Mo Daojun, Lamberts Steven W J, Melmed Shlomo, Cavagnini Francesco, Pecori Giraldi Francesca, Strasburger Christian J, Zimmermann Alan G, Woodmansee Whitney W, Woodmansee Whitney W
Metabolic, cardiovascular, and cerebrovascular outcomes in growth
hormone-deficient subjects with previous cushing's disease or
non-functioning pituitary adenoma
The Journal of clinical endocrinology and metabolism,
2010; 95(2):
630-8.
Ben-Shlomo Anat, Melmed Shlomo
Acromegaly
Endocrinology and metabolism clinics of North America,
2008; 37(1):
101-22, viii.
Chesnokova Vera, Zonis Svetlana, Kovacs Kalman, Ben-Shlomo Anat, Wawrowsky Kolja, Bannykh Serguei, Melmed Shlomo
p21(Cip1) restrains pituitary tumor growth
Proceedings of the National Academy of Sciences of the United States of America,
2008; 105(45):
17498-503.
Ben-Shlomo Anat, Pichurin Oxana, Barshop Nicole J, Wawrowsky Kolja A, Taylor John, Culler Michael D, Chesnokova Vera, Liu Ning-Ai, Melmed Shlomo
Selective regulation of somatostatin receptor subtype signaling:
evidence for constitutive receptor activation
Molecular endocrinology (Baltimore, Md.),
2007; 21(10):
2565-78.
Melmed Shlomo, Sternberg Richard, Cook David, Klibanski Anne, Chanson Philippe, Bonert Vivien, Vance Mary Lee, Rhew David, Kleinberg David, Barkan Ariel
A critical analysis of pituitary tumor shrinkage during primary
medical therapy in acromegaly
The Journal of clinical endocrinology and metabolism,
2005; 90(7):
4405-10.
Akino Kozo, Akita Sadanori, Mizuguchi Toru, Takumi Ichiro, Yu Run, Wang Xhi-yong, Rozga Jacek, Demetriou Achilles A, Melmed Shlomo, Ohtsuru Akira, Yamashita Shunichi
A novel molecular marker of pituitary tumor transforming gene involves
in a rat liver regeneration
The Journal of surgical research,
2005; 129(1):
142-6.
Bronstein Marcello D, Melmed Shlomo
[Pituitary tumorigenesis]
Arquivos brasileiros de endocrinologia e metabologia,
2005; 49(5):
615-25.
Clemmons David R, Chihara Kazuo, Freda Pamela U, Ho Ken K Y, Klibanski Anne, Melmed Shlomo, Shalet Stephen M, Strasburger Christian J, Trainer Peter J, Thorner Michael O
Optimizing control of acromegaly: integrating a growth hormone
receptor antagonist into the treatment algorithm
The Journal of clinical endocrinology and metabolism,
2003; 88(10):
4759-67.